Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12533861 | 1.00 | CYP1A2 (0.46) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL9581080 | 1.00 | CYP1A2 (0.46) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL20872019 | 1.00 | CYP1A2 (0.46) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL19801911 | 0.98 | CYP1A2 (0.45) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL258156 | 0.98 | MAPT (0.44) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL1702986 | 0.98 | MAPT (0.44) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL512533 | 0.98 | MAPT (0.44) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL15713960 | 0.96 | TAAR1 (0.44) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL20871543 | 0.93 | CYP1A2 (0.41) | CYP1A2TAAR1MAPTKDM4EALDH1A1 | |
| SCHEMBL23308243 | 0.92 | TAAR1 (0.52) | CYP1A2TAAR1MAPTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217811-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| US-20230217811-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| US-11641775-B2 | Compounds and organic electronic devices | MERCK PATENT GMBH (DE) | 2023-05-02 | — | — | US | disclosed |
| US-11641775-B2 | Compounds and organic electronic devices | MERCK PATENT GMBH (DE) | 2023-05-02 | — | — | US | disclosed |
| US-20210151682-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2021-05-20 | — | — | US | disclosed |
| US-10944058-B2 | Compounds and organic electronic devices | MERCK PATENT GMBH (DE) | 2021-03-09 | — | — | US | disclosed |
| US-20200287140-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-09-10 | — | — | US | disclosed |
| WO-2019066250-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | 덕산네오룩스 주식회사 | 2019-04-04 | — | — | WO | disclosed |
| EP-3424907-A2 | CONNECTIONS AND ORGANIC ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2019-01-09 | — | — | EP | disclosed |
| EP-2875004-B1 | FLUORENES AND ELECTRONIC DEVICES CONTAINING THEM | MERCK PATENT GMBH (DE) | 2018-07-18 | — | — | EP | disclosed |
| US-20180097178-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-04-05 | — | — | US | disclosed |
| US-20180097178-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-04-05 | — | — | US | disclosed |
| US-9882142-B2 | Compounds and organic electronic devices | MERCK PATENT GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-9882142-B2 | Compounds and organic electronic devices | MERCK PATENT GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-20150179940-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-06-25 | — | — | US | disclosed |
| US-20150179940-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10944058-B2 | Compounds and organic electronic devices | ETV6, CYP2C19, AFF2 | CYP1A2 41/4885TAAR1 2112/4885MAPT 1886/4885 |
| US-20230217811-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | ETV6, CYP2C19, AFF2 | CYP1A2 41/4885TAAR1 2112/4885MAPT 1886/4885 |
| US-20210151682-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | ETV6, CYP2C19, AFF2 | CYP1A2 41/4885TAAR1 2112/4885MAPT 1886/4885 |
| US-11641775-B2 | Compounds and organic electronic devices | ETV6, CYP2C19, AFF2 | CYP1A2 41/4885TAAR1 2112/4885MAPT 1886/4885 |
| US-20200287140-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | OR51E2, PIEZO1, OR10J3 | CYP1A2 556/4885TAAR1 2842/4885MAPT 2612/4885 |
| US-20180097178-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | ETV6, CYP2C19, AFF2 | CYP1A2 41/4885TAAR1 2112/4885MAPT 1886/4885 |
| US-20150179940-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | ETV6, CYP2C19, AFF2 | CYP1A2 41/4885TAAR1 2112/4885MAPT 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.